Reaction

Application Site Hyperaesthesia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 99 reports · 4 co-occurring drugs

As of the last recalculation, Application Site Hyperaesthesia appears in 99 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is NICOTINE (PRR 202.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Nicotine28202.5202.7
Glycerin, Lidocaine7113.0113.1
Docosanol7108.0108.0
Crisaborole367.867.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.